Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    5 March 2024

    Beyond sleep apps: The power of human support in insomnia recovery

    Salus Wellness Clinics writes...In the quest for better sleep, a myriad of digital solutions beckon, promising relief from restless nights. Yet, amidst the allure of sleep apps and digital platforms, the age-old remedy of human support shines bright, offering personalized guidance and s...

    5 March 2024

    Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

    EXN407 is the first topical SRPK1 inhibitor to demonstrate both safety and signals of biological response as monotherapy for these indications Data generated fully support continued clinical development of EXN407 into the CLEAR-DM Phase IIb study Full Phase Ib/IIa data selected for ...

    1 April 2024

    Advanced Threat Group (ATG) & CyberScale Strategic Alliance

    On 1st April 2024 CyberScale and Advanced Threat Group (ATG) formally recognised a strategic alliance aimed at providing their clients with an optimal combination of strategic advice and technical support around Cyber & Information Security. ...

    4 March 2024

    SolasCure publishes Phase IIa Clinical Trial Report in leading Wound Care Journal

    Publication in the ‘International Wound Journal’ provides robust validation of the Phase IIa trial data that will enable further clinical studies Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounds Cambridge, U...

    15 February 2024

    'I was only doing my job'. No-one has the right to obey

    High Performance Change writes...Subordination doesn't justify abdication. A Post Office investigator's defence that 'I was only doing my job' isn't enough. Interestingly, the skills you need to be able to look yourself in the mirror happen to be the same ones that underpin your ability...

    29 February 2024

    Transforming Healthcare Podcast: The importance of collaboration and cooperation in healthcare

    In this episode, Dr Bipin Patel reunites with Tony Jones, Chief Executive of One Nucleus, a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. They support institutions, companies and individuals in the Life Sciences sector providing l...

    28 February 2024

    SPT Labtech and RevoluGen demonstrate fully automated Bead-Based High Molecular Weight DNA Extraction

    The collaboration delivers a walk-away solution suitable for high-throughput long-read sequencing in under two hours. ...

    21 February 2024

    Challenges to a dual: What makes a dual-brand approach viable?

    Pharmaceutical and biologic therapies are increasingly demonstrating their effectiveness in the treatment of multiple diseases. As the trend of therapies being studied and demonstrating effectiveness across multiple indications accelerates, manufacturers are pursuing different approache...

    28 February 2024

    Bio-Rad launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for cell and gene therapy production

    Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet Digital™ PCR During Cell and Gene Therapy Production ...

    27 February 2024

    2024 Corazon's Charity of the Year

    Corazon Health is delighted to announce that EACH (East Anglia's Children's Hospices) has been chosen as their 2024 Charity of The Year, following a selection process that included a vote by employees. The charity supports families and provides care for children and young peop...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 154
    • Page 155
    • Current page 156
    • Page 157
    • Page 158
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS